ideayabio.com (IDYA) Company Sales Revenue

The development of precision oncology through alliances with pharma behemoths carries risks evident in the sales monitoring of IDEAYA Biosciences (IDYA); currently, the current parameter is 0.04. Attracting top chemists via stock options supports innovation, yet a high concentration in early-stage assets creates binary threats to capital, necessitating a gradual expansion of the partnership portfolio to stabilize the business.

IDYA IDEAYA Biosciences, Inc. Revenue and Sales Volume (07/04/2022 - 11/14/2026)

Comprehensive metric breakdowns and analytics for IDEAYA Biosciences, Inc. (IDYA)

- price and consensus price forecast:

Stock Price IDEAYA Corp|IDYA - Price Target Chart

- market capitalization details:

Market Value IDEAYA Biosciences, Inc.|IDYA - Enterprise Value

- balance sheet net asset value indicators:

Book Value of One Share IDEAYA Biosciences|IDYA - Book Capitalization|Market-to-Book Ratio ideayabio.com|IDYA - Cumulative Company Assets

- debt and solvency information:

Aggregate Debt to Capital IDEAYA Biosciences|IDYA - Long-Term Debt to Capital|Current Liabilities to Capital IDEAYA Biosciences Inc|IDYA - Company Aggregate Debts|Debt to Book Value Ratio IDEAYA Biosciences, Inc.|IDYA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings IDEAYA Biosciences|Intermediate Liquidity Ratio ideayabio.com

- earnings and multiples data:

IDYA - Net Profit|Expected Net Income IDEAYA Biosciences|IDYA - P/E Multiple|Projected Price to Earnings Ratio ideayabio.com|IDYA - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation IDEAYA Biosciences, Inc.|IDYA - Operating profit EBITDA|Net earnings per share (EPS TTM) IDEAYA Biosciences|IDYA - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months ideayabio.com|IDYA - Net earnings per share growth this year|Expected net earnings per share growth next year IDEAYA Biosciences

- company sales and revenue statistics:

IDYA - Revenue and Sales Volume|Company Future Sales IDEAYA Corp|IDYA - P/S Multiple|Market Cap to Projected Revenue IDEAYA Biosciences, Inc.

Summary company analysis:IDEAYA Corp IDYA

Sales volume measures the aggregate cash flow from core operations, allowing investors to filter out market noise and assess the actual expansion of the business. Analyzing the sales history of IDEAYA Biosciences (IDYA) reveals how the monetization of partnerships with pharma behemoths and the success of darovasertib and IDE397 are transforming the company's R&D potential into sustainable financial growth.

Competing companies